Fidelion Diagnostics Pte. Ltd. on BGLC, Oct 22, 2026
Fidelion Diagnostics Pte. Ltd. now owns 13.4%, as a passive investor.
- Date
- Oct 22, 2026
- Who
- Fidelion Diagnostics Pte. Ltd.
- Fund
- BGLC - BioNexus Gene Lab Corp
- Stake
- 13.4% (392,329 shares)
- Type of notice
- Passive investor
- Document number
- 0001520138-26-000439
Open the original document at the SEC →
We read this document automatically. If something looks wrong, the original is the one that counts.